doi:10.1056/NEJMoa1607141 This study, part of the SUSTAIN-6 trial, investigated the cardiovascular effects of semaglutide in patients with type 2 diabetes and found a potential reduction in cardiovascular events, which might indirectly affect blood pressure
The most common complaints are nausea, constipation, headache, insomnia, and a bump in blood pressure and heart rate and nausea is actually the top reason people stop taking it
At the end of the experiment, rats were weighed and sacrificed under ketamine (90 mg/kg)-xylazine (10 mg/kg) anaesthesia by exsanguination method
Revolution Health Blog
There is no universally agreed-upon clinical protocol for human use, as epithalon has not undergone large-scale phase III clinical trials in Western countries
While Semaglutide GLP-1 can help lose weight effectively for patients within this criteria, you should still follow your physicians recommendations